Tue.Dec 31, 2024

article thumbnail

Obesity: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read obesity stories from the year 2024.

160
160
article thumbnail

MTM Updates Are Coming in 2025

Pharmacy Times

Adding HIV/AIDS to core chronic diseases is a key change.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nonopioid Pain Management: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.

98
article thumbnail

Reimagining Established Drugs Medicines Could Lead to Potential New Applications

Pharmacy Times

The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pfizer ducks out of Sangamo haemophilia A alliance

pharmaphorum

Sangamo is 'surprised and disappointed' by Pfizer's decision to return rights to its gene therapy for haemophilia A after positive phase 3 results

94
article thumbnail

Advancing Lung Cancer Treatment With Bispecific Antibodies: A Review of Amivantamab and Tarlatamab

Pharmacy Times

Bispecific antibodies amivantamab and tarlatamab hold promise for patients.

132
132

More Trending

article thumbnail

ASH 2024: Zanubrutinib Monotherapy, With Obinutuzimab Demonstrates Durable Efficacy and Safety in CLL/SLL

Pharmacy Times

Constantine Tam, MD, discusses zanubrutinib's efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.

123
123
article thumbnail

Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry

Pharma Marketing Network

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. In an industry where lives are at stake, creating compelling, compliant, and effective campaigns can feel like walking a tightrope.

FDA 52
article thumbnail

New data could widen use of Novartis' SMA therapy Zolgensma

pharmaphorum

Phase 3 results with an intrathecal version of Novartis spinal muscular atrophy (SMA) gene therapy could make older children eligible for treatment.

67
article thumbnail

Can you take prednisone for tooth pain?

The Checkup by Singlecare

Prednisone is a medication used to decrease irritation and inflammation in the body. It belongs to a class of drugs called glucocorticoids. There are many different conditions that prednisone is used for, including allergies, asthma, dermatitis, inflammatory bowel disease, arthritis, lymphoma, and leukemia. Its even used for organ transplantation in adults.

Dosage 52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The AI revolution in pharma

pharmaphorum

The AI revolution in pharma and biotech is transforming the healthcare industry. Discover how artificial intelligence is revolutionising drug discovery, precision medicine, and patient care.

article thumbnail

Prednisone anxiety: Why it happens and how to cope

The Checkup by Singlecare

Prednisone is an FDA-approved prescription medication to treat a range of common conditions characterized by inflammation caused by the immune system. It belongs to a class of drugs called corticosteroids (sometimes called glucocorticoids ). Like other steroids, prednisone reduces swelling, redness, and other symptoms caused by immune system reactions.

Dosage 52
article thumbnail

Frances Abanonu: the power of childhood dreams

Blog: Ask a Student Pharmacist

Frances Abanonu: the power of childhood dreams eomizowh Tue, 12/31/2024 - 12:11 Author: Erin Wilson Third-year PharmD student Frances Abanonu knew at age 11 that she wanted to be a pharmacist. Her early career ambitions stemmed from her father, who was chronically ill and passed away when she was very young. She told herself then that she would grow up to manufacture drugs that would keep others alive.

article thumbnail

How long does gabapentin last?

The Checkup by Singlecare

Gabapentin is a prescription medication with multiple uses. Its an anticonvulsant often given to people with epilepsy or seizure disorders, but its also a nerve pain medication that helps decrease symptoms of common disorders like shingles and restless legs syndrome as well as treat chronic pain from nerve damage. With so many uses, gabapentin is prescribed frequently by healthcare providersyou may even have a bottle of it in your medicine cabinet right now from a prior illness or injury.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Winning Healthcare Marketing Strategy: Proven Tactics for Success

Pharma Marketing Network

Table of Contents Sr# Headings 1 Introduction: The Need for Strategy in Healthcare Marketing 2 Crafting a Patient-Centered Marketing Approach 3 Leveraging Digital Tools for Success 4 Future-Proofing Your Healthcare Marketing Strategy Introduction: The Need for Strategy in Healthcare Marketing Building an effective healthcare marketing strategy can feel like solving a complex puzzle.

HIPAA 52
article thumbnail

Does Aetna cover Nurtec?

The Checkup by Singlecare

Nurtec ODT (rimegepant) is a brand-name antimigraine drug approved by the Food and Drug Administration (FDA) to treat acute migraines and prevent episodic migraines for adults. Healthcare providers will prescribe this medication to patients who have attempted other types of migraine management or are sensitive to other classes of drugs, such as serotonin-receptor agonists (triptans).

article thumbnail

Pharmacy Trends to Look Out For in 2025 (and PioneerRx Features That Can Help)

PioneerRx

As we step into 2025, the pharmacy landscape is evolving rapidly, bringing new opportunities and challenges for independent pharmacies. Staying ahead of these.

article thumbnail

Is Aimovig covered by Medicaid?

The Checkup by Singlecare

One moment, youre ripping through your to-do list. The next, youre floored by a migraine. Between the pain, sensitivity to light, nausea, and vision disturbances, migraines can derail an entire day and keep you bedridden for hours on end. Thats why Aimovig (erenumab-aooe) comes as such a reassurance. Its the first prescription drug approved by the Food and Drug Administration (FDA) to prevent migraines before they strike, and clinical trials have proven its ability to reduce monthly migraine day

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership

Pharmaceutical Technology

Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.

52
article thumbnail

Leveraging Technology and Data for Personalized Fertility Treatment

PharmExec

In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), talks about advancements in technology and data analysis that could lead to more personalized fertility treatments.

52
article thumbnail

Top 3 Examples of Conference Coverage This Year

Pharmaceutical Commerce

Pharma Commerce was on the road extensively throughout 2024, and plenty of insight was gathered along the way.

52
article thumbnail

2024’s Biggest Marketing Stories

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Can you take glimepiride and metformin together?

The Checkup by Singlecare

Metformin and glimepiride are two generic medications that have been approved to treat Type 2 diabetes since 1995. Since Type 2 diabetes is associated with other health risks, such as high blood pressure, heart disease, and stroke, its extremely important for diabetes patients to treat their symptoms and high blood sugar before they become worse. Considering the fact that both of these Type 2 diabetes medications have unique benefits, some people may wonder whether its advisable to take them tog

article thumbnail

STAT+: Four digital health unicorns on what they expect in 2025

STAT

For many of the biggest fish in digital health, 2024 went swimmingly. As the year comes to a close, STAT caught up with leaders from four of the most significant privately-held digital health companies: Omada Health, Transcarent, Hinge Health, and Maven Clinic. Two of them raised “mega rounds” totaling over $100 million each in 2024 and the other two are rumored to be on their way to public offerings next year.

84
article thumbnail

Is Quviviq covered by Blue Cross Blue Shield?

The Checkup by Singlecare

Quviviq (daridorexant) is a brand-name medication approved by the Food and Drug Administration (FDA) to treat insomnia (difficulty with sleep onset or sleep maintenance) in adults. Quviviq is a medication that is a dual orexin receptor antagonist (DORA)a fancy way of saying that this medication blocks orexin, a substance found in the brain that is involved in wakefulness and arousal, says Brittney Jones, Psy.D., a licensed clinical psychologist, a board-certified insomnia specialist, and founder

article thumbnail

Opinion: The most read First Opinion essays of 2024

STAT

I think it’s fair to say that everyone expected 2024 to be a little wild, given the U.S. presidential election. But what ended up transpiring this year — particularly when it comes to health, medicine, and the life sciences — became more dramatic than I, at least, had expected: a resurgence of the conversation about vaccines, the shooting of UnitedHealthcare CEO Brian Thompson and the ensuing backlash to the insurance industry, upheaval around weight loss drugs, and so much

article thumbnail

Does losartan cause hair loss?

The Checkup by Singlecare

Losartan is a generic medication used to treat a variety of conditions. It is approved by the Food and Drug Administration (FDA) to treat hypertension (high blood pressure) and diabetic nephropathy. It also has several off-label uses (uses not approved by the FDA), such as treating heart failure. Although many people with hypertension take medications like losartan, which is available as brand-name Cozaar, they do come with some common side effects, namely headache, dizziness, and upset stomach.

FDA 52
article thumbnail

STAT+: 3 key issues to watch at the FDA as Trump takes office

STAT

The Food and Drug Administration’s leadership and agenda is about to change, making 2025 a critical year for the agency.  With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening regulation on raw milk, more harshly scrutinizing the safety of vaccines, and cracking down on ultra-processed foods and additives.

FDA 84